Bazemore Todd - Insider Non-Derivative Transactions at Kala Pharmaceuticals, Inc. (KALA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 26, 2024, Bazemore Todd's relationship to Kala Pharmaceuticals, Inc. (KALA) is Officer (SEE REMARKS), and currently has 83,040 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KALA insiders.
Data Source: SEC.
Bazemore Todd - Insider Non-Derivative Transactions of KALA Common Stock
Bazemore Todd - Insider Non-Derivative Transactions at KALA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 27, 2024 | Sell -- (Common Stock) | 4653 | 4.75 | 83040 |
| Jun 1, 2024 | Sell -- (Common Stock) | 2093 | 6.09 | 87693 |
| Jan 5, 2024 | Sell -- (Common Stock) | 1405 | 6.74 | 0 |
| Jan 5, 2024 | Acquisition -- (Common Stock) | 6500 | 0 | 0 |
| Jun 23, 2023 | Acquisition -- (Common Stock) | 48698 | 0 | 84691 |
| Jun 1, 2023 | Acquisition -- (Common Stock) | 21158 | 0 | 35993 |
| Jan 5, 2023 | Sell -- (Common Stock) | 62 | 28.54 | 14835 |
| Jan 5, 2023 | Acquisition -- (Common Stock) | 12800 | 0 | 14897 |